All Stories

Hemogenyx: a doctor writes again and some Estonian number crunching

Tom Winnifrith
Wednesday 24 September 2025
Yesterday Hemogenyx (HEMO) announced that it had signed a letter of intent with Cellin Technologies OU in Estonia claiming that this “represents the first near term revenue opportunity.” Let me and also a qualified doctor with expertise in clinical trials, explain why that is just Vlad Sandler over-egging the pudding big time.. And why that ultimately consigns all involved in this spoof to a special place in hell. 

on Tom Winnifrith | Comments
About Tom Winnifrith
Bio
Tom Winnifrith is the editor of TomWinnifrith.com. When he is not harvesting olives in Greece, he is (planning to) raise goats in Wales.
Twitter
@TomWinnifrith
Email
[email protected]
Recently Featured on ShareProphets
Sign up for my weekly newsletter








Required Reading

Recent Comments


I also read